Literature DB >> 15261821

Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry.

Chunhui Deng1, Xiangmin Zhang, Ning Li.   

Abstract

In the present work, solid-phase microextraction (SPME) and gas chromatography-mass spectrometry (GC-MS) was developed for investigation of lung cancer volatile biomarkers. Headspace SPME conditions (fiber coating, extraction temperature and extraction time) and desorption conditions were optimized and applied to determination of volatiles in human blood. To find the biomarkers of lung cancer, investigation of volatile compounds in lung cancer blood and control was performed by using the present method. Concentrations of hexanal and heptanal in lung cancer blood were found to be much higher than those in control blood. The two molecules of hexanal and heptanal were regarded as biomarkers of lung cancer. By comparison of volatiles in breath and in blood, it is demonstrated that hexanal and heptanal in breath were originated from blood and screening of lung cancer by breath analysis be feasible. These results show that SPME/GC-MS is a simple, rapid and sensitive method very suitable for investigation of volatile disease markers in human blood.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15261821     DOI: 10.1016/j.jchromb.2004.05.015

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  31 in total

1.  Comparison of the volatile organic compounds present in human odor using SPME-GC/MS.

Authors:  Allison M Curran; Scott I Rabin; Paola A Prada; Kenneth G Furton
Journal:  J Chem Ecol       Date:  2005-07       Impact factor: 2.626

2.  Metabolic profiling of oxidized lipid-derived volatiles in blood by gas chromatography/mass spectrometry with in-tube extraction.

Authors:  Shoji Kakuta; Yasuhiko Bando; Shin Nishiumi; Masaru Yoshida; Eiichiro Fukusaki; Takeshi Bamba
Journal:  Mass Spectrom (Tokyo)       Date:  2013-04-26

Review 3.  The clinical potential of exhaled breath analysis for diabetes mellitus.

Authors:  Timothy Do Chau Minh; Donald Ray Blake; Pietro Renato Galassetti
Journal:  Diabetes Res Clin Pract       Date:  2012-03-10       Impact factor: 5.602

4.  Effect of age and storage conditions on the volatile organic compound profile of blood.

Authors:  Shari L Forbes; LaTara Rust; Kate Trebilcock; Katelynn A Perrault; Laura T McGrath
Journal:  Forensic Sci Med Pathol       Date:  2014-10-29       Impact factor: 2.007

5.  Characteristic odour in the blood reveals ovarian carcinoma.

Authors:  György Horvath; Håkan Andersson; Gunnar Paulsson
Journal:  BMC Cancer       Date:  2010-11-24       Impact factor: 4.430

6.  Sugar-fermenting yeast as an organic source of carbon dioxide to attract the malaria mosquito Anopheles gambiae.

Authors:  Renate C Smallegange; Wolfgang H Schmied; Karel J van Roey; Niels O Verhulst; Jeroen Spitzen; Wolfgang R Mukabana; Willem Takken
Journal:  Malar J       Date:  2010-10-25       Impact factor: 2.979

7.  Differential volatile signatures from skin, naevi and melanoma: a novel approach to detect a pathological process.

Authors:  Tatjana Abaffy; Robert Duncan; Daniel D Riemer; Olaf Tietje; George Elgart; Clara Milikowski; R Anthony DeFazio
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

8.  Gas sensing with high-resolution localized surface plasmon resonance spectroscopy.

Authors:  Julia M Bingham; Jeffrey N Anker; Lauren E Kreno; Richard P Van Duyne
Journal:  J Am Chem Soc       Date:  2010-11-22       Impact factor: 15.419

9.  Accuracy and Methodologic Challenges of Volatile Organic Compound-Based Exhaled Breath Tests for Cancer Diagnosis: A Systematic Review and Meta-analysis.

Authors:  George B Hanna; Piers R Boshier; Sheraz R Markar; Andrea Romano
Journal:  JAMA Oncol       Date:  2019-01-10       Impact factor: 31.777

Review 10.  Assessment, origin, and implementation of breath volatile cancer markers.

Authors:  Hossam Haick; Yoav Y Broza; Pawel Mochalski; Vera Ruzsanyi; Anton Amann
Journal:  Chem Soc Rev       Date:  2013-12-04       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.